Lithium and haloperidol treatments differently affect the mononuclear leukocyte gas protein levels in bipolar affective disorder

Neuropsychobiology

Volumn 39, Issue 4, 1999, Pages 181-186

  Karege, Félicien ^a   Golaz, Jean ^a   Schwald, Michèle ^a   Malafosse, Alain ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Bipolar affective disorder; Haloperidol; Leukocyte G s protein; Lithium

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; HALOPERIDOL; LITHIUM; NEUROLEPTIC AGENT; PROTEIN SUBUNIT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FACTORIAL ANALYSIS; FEMALE; HUMAN; IMMUNOBLOTTING; MALE; MANIC DEPRESSIVE PSYCHOSIS; MONOCYTE; MOOD; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS;

ADULT; AGED; ANIMALS; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; BLOTTING, WESTERN; CELL MEMBRANE; FEMALE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HALOPERIDOL; HUMANS; LEUKOCYTES; LITHIUM; MALE; MIDDLE AGED; RATS;

EID: 0032938244     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026581     Document Type: Article

References (35)

1. Gilman AG: G proteins: Transducers of receptor-generated signals. Annu Rev Biochem 1987;56:615-648.
2. Milligan G: Agonist regulation of cellular G protein levels and distribution: Mechanisms and functional implications. Trends Pharmacol Sci 1993;14:413-416.
3. Manji HK, Chen G, Shimon H, Hsiao JK, Potter WZ, Belmaker RH: Guanine-nucleotide binding proteins in bipolar disorder. Effect of long-term treatment. Arch Gen Psychiatry 1995;52:135-144.
4. Manji HK, Potter WZ, Lenox LH: Signal transduction pathways. Molecular targets for lithium's actions, Arch Gen Psychiatry 1995b;52: 531-543.
5. Manji HK: G protein implications for psychiatry. Am J Psychiatry 1992;149:746-760.
6. Avissar S, Schreiber G: The involvement of guanine nucleotide binding proteins in the pathogenesis and treatment of affective disorders. Biol Psychiatry 1992;31:435-459.
7. Mitchel PB, Manji HK, Jolkovisky L, Smith-Jacson E, Denicoff K, Schmidt M, Potter WZ: High levels of Gsα in platelets of euthymic patients with bipolar affective disorder. Am J Psychiatry 1997;154:218-223.
8. Young LT, Li PP, Kish SJ, Siu KP, Warsh JJ: Postmortem cerebral cortex, Gs alpha subunit levels are elevated in bipolar affective disorder. Brain Res 1991;553:323-326.
9. Young LT, Li PP, Kamble A, Siu KP, Warsh JJ: Mononuclear leukocyte levels of G proteins in depressed patients with bipolar disorder or major depressed disorder. Am J Psychiatry 1994;151:594-596.
10. Avissar S, Barki-Harrington L, Nechamkin Y, Roitman G, Schreiber G: Reduced ß-adrenergic receptor-coupled Gs protein function and Gsα immunoreactivity in mononuclear leukocytes of patients with depression. Biol Psychiatry 1996;39:755-760.
11. Young LT, Li PP, Kish SJ, Siu KP, Kamble A, Hornykiewicz O, Warsh JJ: Cerebral cortex Gαs protein levels and forskolin-stimulated cAMP formation are increased in bipolar affective disorder. J Neurochem 1993;61:890-898.
12. Friedman E, Wang H-Y: Receptor-mediated activation of G proteins is increased in postmortem brains of bipolar affective disorder subjects. J Neurochem 1996;67:1145-1152.
13. Lesch KP, Manji HK: Signal transducing G proteins and antidepressant drugs: Evidence for modulation of a subunit gene expression in rat brain. Biol Psychiatry 1992;32:449-579.
14. Li PP, Young LT, Tam YT, Sibony D, Warsh JJ: Effects of chronic lithium and carbamazepine treatment on G-protein subunit expression in rat cerebral cortex. Biol Psychiatry 1993;34:162-170.
15. Shin CJ, Kim YS, Park J-B, Juhnn Y-S: Changes in G protein levels in the hippocampus and in the stratum of rat brain after chronic treatment with haloperidol and sulpiride. Neuropharmacology 1995;34:1335-1338.
16. 2α) mRNA expression after electroconvulsive shock of lithium carbonate treatment. Eur J Pharmacol 1996;306:249-255.
17. Young LT, Li PP, Kamble A, Siu KP, Warsh JJ: Lack of effect of antidepressants on mononuclear leukocyte G-protein levels or function in depressed outpatients. J Affective Disord 1996;39:201-207.
18. Young LT, Woods CM, Robb JC, Patelis-Siotis I, Asghari V, Sokolov ST: Platelet endogenous adenosine 5′-diphosphate ribosylation in drug-free and lithium-treated subjects with bipolar disorder. Biol Psychiatry 1997;42:413-415.
19. Freeman MP, Stoll AL: Mood stabilizer combinations: A review of safety and efficacy. Am J Psychiatry 1998;155:12-21.
20. Solomon DA, Keitner GI, Ryan CE, Miller IW: Lithium plus valproate as maintenance polypharmacy for patients with bipolar disorder: A review: J Clin Psychopharmacol 1998;18:38-49.
21. American Psychiatric Association: DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders, vers 3, revised. Washington, American Psychiatric Association, 1987.
22. Nurnberger JI: Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 1994;51:849-859.
23. Boyum A: Isolation of mononuclear cells and granulocytes from blood. II: Isolation of mononuclear cells by one centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest 1968; 21:77-89.
24. Bradford MM: A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1968;72:248-254.
25. Karege F, Bovier P, Stepanian R, Gaillard JM: Change in platelet GTP-binding protein in drug-free depressed patients. Hum Psychopharmacol 1996;11:115-121.
26. Risby ED, Hsiao JK, Manji HK, Bitran J, Moses F, Zhou DF, Potter WZ: The mechanisms of action of lithium. II. Effects on adenylate cyclase activity and beta-adrenergic receptor binding in normal subjects. Arch Gen Psychiatry 1991;48:513-524.
27. Mooney JJ, Samson JA, McHale NL, Colodzin R, Alpert J, Koutsos M, Schildkraut JJ: Signal transduction by platelet adenylate cyclase: Alterations in depressed patients may reflect impairment in the coordinated integration of cellular signals (coincidence detection). Biol Psychiatry 1998;43:574-583.
28. Schreiber G, Avissar S, Danon A, Belmaker RH: Hyperfunctional G proteins in mononuclear leukocytes of patients with mania. Biol Psychiatry 1991;29:273-280.
29. Jakobsen SN, Wiborg O: Selective effects of longterm treatment and carbamazepine administration on G protein subunit expression in rat brain. Brain Res 1998;780:46-55.
30. Li X, Jope RS: Selective inhibition of the expression of signal transduction proteins by lithium in nerve growth factor-differentiated PC-12 cells. J Neurochem 1995;65:2500.
31. Baraban JM, Worley PF, Synder SH: Second messenger systems and psychoactive drug action: Focus on the phosphoinositide system and lithium. Am J Psychiatry 1989;146:1251-1260.
32. Mork A, Geissler A: Effects of chronic lithium treatment on agonist-enhanced extracellular concentration of cyclic AMP in the dorsal hippocampus of freely moving rats. J Neurochem 1995;65:134.
33. Mork A, Geissler A: The effects of lithium in vitro and ex-vivo on adenylate cyclase in brain are exerted by distinct mechanisms. Neuropharmacology 1989;28:307-311.
34. Manji HK, Bitran JA, Masana MI, Chen JA, Hsiao JK, Risby ED, Rudorfer MV, Potter WZ: Signal transduction modulation by lithium: Cell culture, cerebral microdialysis and human studies. Psychopharmacol Bull 1991; 27:199-208.
35. Gupta SK, Mishra RK: Effects of chronic treatment of haloperidol and clonazepine on levels o G protein subunits in rat striatum. J Mol Neurosci 1992;3:197-201.